A Diverse Team of Experts. A Singular Focus.
As a group of seasoned industry experts, the Next Science team has championed medtech innovation through the years. The team is advancing groundbreaking discoveries with synergistic industry and research partnerships and developing effective solutions that contest the problem of antimicrobial resistance caused by biofilms, a known threat to public health.
Judith Mitchell joined the Next Science team as Managing Director in August 2017. Previously, as President of Depuy Synthes Asia Pacific, Ms. Mitchell lead the Orthopaedics Division of J&J. She was also the President of Asia Pacific for Synthes GmbH, the world leader in Orthopaedic trauma care. Before joining Synthes in 2004, she held several senior positions at Cochlear Limited in Product Development, Global Marketing and Education.
She also brings with her over 14 years of med tech expertise at GE Medical Systems spanning across Sales, Marketing and Management.
Dr. Matthew Myntti
Chief Technology Officer
As the founder and CTO of Next Science, Dr. Matt Myntti oversees and manages all aspects of R&D and product ideation of Next Science technologies. He received his Master’s and Doctoral degrees in Materials Science and Engineering from the University of Dayton and has over 28 granted US patents. Dr. Myntti previously led the biomaterials group at Medtronic Surgical Technologies, which developed novel ENT and neurologic products.
Chief Operating Officer
Jon Swanson joined the Next Science team in June 2018 as the Chief Operating Officer to lead our operations, quality and regulatory teams. Mr. Swanson joins us from McKinsey & Co., where as the Head of the Advanced Operations Group, he focused on client operational improvement, product development and quality performance for pharma and medical product industries since 2011.
Prior to that, Mr. Swanson spearheaded manufacturing, product development and operational excellence at Medtronic in multiple leadership roles. As a professional rooted in operations and nuclear engineering excellence, he started his career in the US Navy.
He holds a Master’s Degree in Business Administration from the University of Florida and a Bachelor’s Degree in Mathematics from the US Naval Academy.
Chief Financial Officer
Jacqueline Butler is the Chief Financial Officer at Next Science. She’s a certified Chartered Accountant from the Institute of Chartered Accountants, England and Wales (ICAEW) during her time at Arthur Andersen in London. She was in several financial roles in the UK and Europe and moved to Australia in 2005. She was the acting CFO for her client portfolio and the Head of Accounting and Financial Reporting Divisions as Associate Director at Azure Group Pty Ltd.. She then went on to become the CFO and Company Secretary for Avira Energy Limited in 2013, helping to list the company on the ASX in 2013.
Executive VP, Partnerships
As the Executive VP at Next Science, Byron Darroch leads the partnerships team at the company. Credited for designing innovative business models and strategies, Mr. Darroch has constantly challenged archaic industry operation models through his work.
As the General Manager and Head of Business Development at Atomo Diagnostics, (supported by the Gates Foundation) Mr. Darroch propelled the diagnostics company forward by helping them bring large-scale HIV self-testing to the global market.
Mr. Daniel Canon is the VP, Operations at Next Science.
As the former Senior Engineering Manager at Medtronic, he managed strategic company acquisitions, development and execution of subsequent business integration strategies to assure top notch medical device production quality.
An industry veteran with over 20 years of experience, Mr. Canon has lead complex projects in military, commercial, defense and medical operational environments. He has a Bachelor's Degree in Electrical Engineering from Pennsylvania State University and a Master’s Degree in Mechanical Engineering from the University of Maryland.
VP, Sales and Marketing
Don Ayers brings over 25 years of healthcare experience to Next Science. With a specialized focus on introduction and commercialization of advanced and innovative products to marketplace, Mr. Ayers has acted as National Account Director and in several sales leadership roles for several fast growing companies such as MiMedx, Shire, Advanced BioHealing, and Smith & Nephew.
At Next Science, Mr. Ayers presides over sales and market development initiatives in the US.
VP, Quality Assurance
As the VP of Quality Assurance at Next Science, Susan Johnson heads the growth and development of the Quality Management System at the company. With over 20 years of quality engineering experience, Susan is an expert having had several prominent positions in the medical device industry.
For 13 years she worked across the spectrum with engineering, managerial roles and as a key supplier quality manager for a global supply base at Medtronic. She received her Bachelor of Science Degree in Industrial Engineering from Hofstra University.
MPN-WEB-006 Rev B